Apr 27, 2020
Global Osteoarthritis Pipeline Study, H1 2020 - Therapeutics, Developments, Products, Drugs, Players
Oct 23, 2019
$10+ Billion Osteoarthritis Therapeutics Markets, 2024 by Anatomy, Drug Type, Route of Administration, Distribution Channel, Purchasing Pattern
Oct 15, 2019
Osteoarthritis Therapeutics Market Worth $10.1 Billion by 2024 - Exclusive Report by MarketsandMarkets(TM)
Oct 15, 2018
Golden Future Expos Inc. Announces Flexion Therapeutics, Inc. as the Presenting Sponsor at the Upcoming Orange County 50+ Senior Expo
Jun 13, 2018
Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
May 03, 2018
Technical Perspectives on Generic Drugs Stocks -- Allergan, Catalyst Pharma, Flexion Therapeutics, and Supernus Pharma
Mar 29, 2018
Quotidian Technical Highlights on Selected Generic Drugs Stocks -- Allergan, Catalyst Pharma, Flexion Therapeutics, and Supernus Pharma
Feb 22, 2018
Quotidian Technical Highlights on Selected Generic Drugs Stocks -- Allergan, Catalyst Pharma, Flexion Therapeutics, and Supernus Pharma
Nov 16, 2017
Generic Drugs Stock Performance Review -- Catalyst Pharma, Flexion Therapeutics, Supernus Pharma and Allergan
Oct 10, 2017
Generic Drugs Stock Performance Review -- Catalyst Pharma, Flexion Therapeutics, Supernus Pharma, and Allergan
Oct 09, 2017
Flexion Therapeutics to Hold Conference Call at 8:00 a.m. ET to Discuss Recent FDA Approval of ZILRETTA(TM) (triamcinolone acetonide extended-release injectable suspension)